Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. [electronic resource]
Producer: 20070425Description: 342-8 p. digitalISSN:- 1592-8721
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antigens, CD -- biosynthesis
- Antigens, Differentiation, Myelomonocytic -- biosynthesis
- Antigens, Neoplasm -- biosynthesis
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Blood Cell Count
- Burkitt Lymphoma -- blood
- CD13 Antigens -- biosynthesis
- Cell Lineage
- Cohort Studies
- Combined Modality Therapy
- Cranial Irradiation
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Disease-Free Survival
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Female
- Humans
- Immunophenotyping
- Leukemia-Lymphoma, Adult T-Cell -- blood
- Male
- Middle Aged
- Multicenter Studies as Topic -- statistics & numerical data
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- blood
- Prognosis
- Radiotherapy, Adjuvant
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Remission Induction
- Sialic Acid Binding Ig-like Lectin 3
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.